Works matching IS 03618609 AND DT 2011 AND VI 86 AND IP 3


Results: 26
    1
    2

    Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 3, p. 318, doi. 10.1002/ajh.21942
    By:
    • Zackova, Daniela;
    • Klamova, Hana;
    • Dusek, Ladislav;
    • Muzik, Jan;
    • Polakova, Katerina Machova;
    • Moravcova, Jana;
    • Jurcek, Tomas;
    • Dvorakova, Dana;
    • Racil, Zdenek;
    • Pospisil, Zdenek;
    • Oltova, Alexandra;
    • Michalova, Kyra;
    • Brezinova, Jana;
    • Razga, Filip;
    • Doubek, Michael;
    • Cetkovsky, Petr;
    • Trneny, Marek;
    • Mayer, Jiri
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    My home is my castle.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 3, p. 303, doi. 10.1002/ajh.21940
    By:
    • Zeitlin, Inna;
    • Beigel, Roy;
    • Vaknine, Hananya;
    • Potachenko, Paolina;
    • Beigel, Yitzhak
    Publication type:
    Article
    15

    Malaria pigment.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 3, p. 302, doi. 10.1002/ajh.21944
    By:
    • Bain, Barbara J.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    G6PD deficiency and stroke in the CSSCD.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 3, p. 331, doi. 10.1002/ajh.21958
    By:
    • Miller, Scott T.;
    • Milton, Jacqueline;
    • Steinberg, Martin H.
    Publication type:
    Article
    25
    26